{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:40:04Z","timestamp":1792773604669,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejps.2026.107696","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:41:46Z","timestamp":1792770106000},"page":"107696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of the LeiCNS-PK model to quantitatively evaluate the roles of BBB active influx and brain metabolism of fluvoxamine and its serotonin transporter (SERT) occupancy in rat and human"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6657-0178","authenticated-orcid":false,"given":"Mengxu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4150-3486","authenticated-orcid":false,"given":"Vivi","family":"Rottsch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8303-1117","authenticated-orcid":false,"given":"Elizabeth CM","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejps.2026.107696_bib0001","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1208\/s12248-013-9496-0","article-title":"Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier\u2013towards a mechanistic IVIVE-based approach","volume":"15","author":"Ball","year":"2013","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.ejps.2026.107696_bib0002","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0893-133X(00)00116-0","article-title":"Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy","volume":"23","author":"Bolo","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.ejps.2026.107696_bib0003","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0009-9236(96)90134-4","article-title":"Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity","volume":"60","author":"Carrillo","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejps.2026.107696_bib0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuint.2016.05.010","article-title":"Spatiotemporal SERT expression in cortical map development","volume":"98","author":"Chen","year":"2016","journal-title":"Neurochem Int"},{"issue":"4","key":"10.1016\/j.ejps.2026.107696_bib0005","first-page":"11","article-title":"Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling","author":"Choi","year":"2019","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejps.2026.107696_bib0006","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1067\/mcp.2002.121788","article-title":"Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19)","volume":"71","author":"Christensen","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ejps.2026.107696_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03188743","article-title":"Fluvoxamine maleate; Disposition in man","volume":"8","author":"De Bree","year":"1983","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"issue":"6","key":"10.1016\/j.ejps.2026.107696_bib0008","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00007691-199212000-00010","article-title":"Single and Multiple Oral Dose Fluvoxamine Kinetics in Young and Elderly Subjects","volume":"14","author":"de Vries","year":"1992","journal-title":"Therapeutic Drug Monitoring"},{"issue":"7","key":"10.1016\/j.ejps.2026.107696_bib0009","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1124\/dmd.111.038778","article-title":"Species independence in brain tissue binding using brain homogenates","volume":"39","author":"Di","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.ejps.2026.107696_bib0010","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1038\/s41380-024-02626-1","article-title":"Antidepressant-induced membrane trafficking regulates blood-brain barrier permeability","volume":"29","author":"Du","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ejps.2026.107696_bib0011","series-title":"FLUVOXAMINE MALEATE ORAL TABLET FDA lable document","year":"2007"},{"issue":"3","key":"10.1016\/j.ejps.2026.107696_bib0012","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0024-3205(94)00876-0","article-title":"Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis","volume":"55","author":"Fuller","year":"1994","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.ejps.2026.107696_bib0013","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2133\/dmpk.18.337","article-title":"CYP2D in the brain","volume":"18","author":"Funae","year":"2003","journal-title":"Drug Metab Pharmacokinet"},{"issue":"4","key":"10.1016\/j.ejps.2026.107696_bib0014","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s11095-007-9390-5","article-title":"Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat","volume":"25","author":"Geldof","year":"2008","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.ejps.2026.107696_bib0015","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/bjp.2008.179","article-title":"Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex","volume":"154","author":"Geldof","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"13","key":"10.1016\/j.ejps.2026.107696_bib0016","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.febslet.2012.05.021","article-title":"Rat CYP2D2, not 2D1, is functionally conserved with human CYP2D6 in endogenous morphine formation","volume":"586","author":"Grobe","year":"2012","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.ejps.2026.107696_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mcp.2000.104071","article-title":"Increased bioavailability of oral melatonin after fluvoxamine coadministration","volume":"67","author":"Hartter","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"D1","key":"10.1016\/j.ejps.2026.107696_bib0018","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.ejps.2026.107696_bib0019","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3109\/10715762.2012.683430","article-title":"Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress","volume":"46","author":"Kobuchi","year":"2012","journal-title":"Free Radic Res"},{"issue":"10","key":"10.1016\/j.ejps.2026.107696_bib0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/psp4.12134","article-title":"Applied Concepts in PBPK Modeling: How to Build a PBPK\/PD Model","volume":"5","author":"Kuepfer","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.ejps.2026.107696_bib0021","series-title":"Characterization of Influx Transporters in the Blood-Brain Barrier: Implications for Drug Delivery UCSF]","author":"Lin","year":"2015"},{"issue":"2","key":"10.1016\/j.ejps.2026.107696_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24304","article-title":"Accurate prediction of K(p,uu,brain) based on experimental measurement of K(p,brain) and computed physicochemical properties of candidate compounds in CNS drug discovery","volume":"10","author":"Ma","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.ejps.2026.107696_bib0023","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/dmd.104.001222","article-title":"Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice","volume":"33","author":"Maurer","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.ejps.2026.107696_bib0024","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/00498250600718464","article-title":"Identification of human cytochrome P450 enzymes involved in the major metabolic pathway of fluvoxamine","volume":"37","author":"Miura","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2026.107696_bib0025","unstructured":"Monolix 2021R2. In. Lixoft SAS, a Simulations Plus company."},{"issue":"2","key":"10.1016\/j.ejps.2026.107696_bib0026","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","article-title":"Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter","volume":"40","author":"Nemeroff","year":"1994","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1016\/j.ejps.2026.107696_bib0027","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1476-5381.2011.01557.x","article-title":"Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings","volume":"165","author":"O'Brien","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.ejps.2026.107696_bib0028","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00003088-199427030-00002","article-title":"Clinical pharmacokinetics of fluvoxamine","volume":"27","author":"Perucca","year":"1994","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1016\/j.ejps.2026.107696_bib0029","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10928-021-09768-7","article-title":"Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations","volume":"48","author":"Saleh","year":"2021","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"10.1016\/j.ejps.2026.107696_bib0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.1013","article-title":"Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective","volume":"104","author":"Shebley","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ejps.2026.107696_bib0031","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2125.1998.00670.x","article-title":"Non-linear fluvoxamine disposition","volume":"45","author":"Spigset","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ejps.2026.107696_bib0032","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archpsyc.60.4.386","article-title":"High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography","volume":"60","author":"Suhara","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.ejps.2026.107696_bib0033","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1152\/physrev.00027.2007","article-title":"Diffusion in brain extracellular space","volume":"88","author":"Sykova","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejps.2026.107696_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2025.100722","article-title":"Dynamic changes of serotonin transporter expression in the prefrontal cortex evoked by aggressive social interactions","volume":"36","author":"Szebik","year":"2025","journal-title":"Neurobiol Stress"},{"issue":"2","key":"10.1016\/j.ejps.2026.107696_bib0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.jcp.0000203201.34323.d3","article-title":"Time course of in vivo 5-HTT transporter occupancy by fluvoxamine","volume":"26","author":"Takano","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.ejps.2026.107696_bib0036","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1023\/A:1016283003747","article-title":"Effect of aging on the kinetics of blood-brain barrier uptake of tryptophan in rats","volume":"12","author":"Tang","year":"1995","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.ejps.2026.107696_bib0037","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s12035-020-01896-4","article-title":"Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice","volume":"57","author":"Tolledo","year":"2020","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.ejps.2026.107696_bib0038","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00003088-199324030-00003","article-title":"Clinical pharmacokinetics of selective serotonin reuptake inhibitors","volume":"24","author":"van Harten","year":"1993","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"10.1016\/j.ejps.2026.107696_bib0039","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/bdd.2510120803","article-title":"Bioavailability of fluvoxamine given with and without food","volume":"12","author":"Van Harten","year":"1991","journal-title":"Biopharm Drug Dispos"},{"issue":"2","key":"10.1016\/j.ejps.2026.107696_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10928-025-10015-6","article-title":"Simulation-based assessment of the P-glycoprotein expression-activity relationship shows a drug and system dependency","volume":"53","author":"van Valkengoed","year":"2026","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"10.1016\/j.ejps.2026.107696_bib0041","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.102.046532","article-title":"Inhibition of P-glycoprotein by newer antidepressants","volume":"305","author":"Weiss","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.ejps.2026.107696_bib0042","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2125.2003.01881.x","article-title":"Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver","volume":"56","author":"Wilson","year":"2003","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.ejps.2026.107696_bib0043","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11095-016-2065-3","article-title":"A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations","volume":"34","author":"Yamamoto","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.ejps.2026.107696_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.985159","article-title":"CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine","volume":"13","author":"Ye","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejps.2026.107696_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106883","article-title":"Exploring K(p,uu,BBB) values smaller than unity in remoxipride: A physiologically-based CNS model approach highlighting brain metabolism in drugs with passive blood-brain barrier transport","volume":"203","author":"Zhang","year":"2024","journal-title":"Eur J Pharm Sci"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:41:52Z","timestamp":1792770112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S0928098726002708"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107696","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of the LeiCNS-PK model to quantitatively evaluate the roles of BBB active influx and brain metabolism of fluvoxamine and its serotonin transporter (SERT) occupancy in rat and human","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107696"}}